The significance of 1793G>A polymorphism in MTHFR gene in women with first trimester recurrent miscarriages

Neuroendocrinology Letters

Volumn 31, Issue 5, 2010, Pages 717-723

  Seremak Mrozikiewicz, Agnieszka ^a   Drews, Krzysztof ^a   Kurzawinska, Grazyna ^a   Bogacz, Anna ^a,b   Grzeskowiak, Edmund ^a   Mrozikiewicz, Przemyslaw M ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

Author keywords

Genetic polymorphism; MTHFR (methylenetetrahydrofolate reductase); Recurrent miscarriages

Indexed keywords

GENOMIC DNA; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ALLELE; ANAMNESIS; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GESTATION PERIOD; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; RECURRENT ABORTION;

EID: 79851504506     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Abbate R, Sofi F, Gensini F, Fatini C, Sticchi E, Fedi S. (2002). Thrombophilias as risk factors for disorders of pregnancy and fetal damage. Pathophysiol Haemost Thromb. 32: 318-321. (Pubitemid 37490561)
2. Also-Rallo E, Lopez-Quesada E, Urreizti R, Vilaseca MA, Lailla JM, Balcells S et al (2005). Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol. 120: 45-52. (Pubitemid 40615071)
3. Altmae S, Stavereus-Evers A, Ruiz JR, Laapere M, Syvanen T, Yngve A et al (2009). Variations in folate pathway genes are associated with unexplained female infertility. Fertil Steril. Epub ahead of print.
4. Arias F, Romero R, Joist H, Kraus FT (1998). Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med. 7: 277-286.
5. Börjel AK, Ynqve A, Sjöström M, Nilsson TK (2006). Novel mutations in the 5′-UTR of the FOLR1 gene. Clin Chem Lab Med. 44: 161-167. (Pubitemid 43237958)
6. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A (2002). Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 17: 1633-1637. (Pubitemid 34661820)
7. Chango A, Boisson F, Barbé F, Quilliot D, Droesch S, Pfister M et al (2000). The effect of 677C - >T and 1298A - >C mutations on plasma homocysteine and 5, 10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr. 83: 593-596. (Pubitemid 30392098)
8. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T et al (2000). Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod. 15: 458-462. (Pubitemid 30076732)
9. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S et al (1999). A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr. 129: 1656-1661. (Pubitemid 29406617)
10. Friso S, Girelli D, Trabetti E, Stranieri C, Olivieri O, Tinazzi E et al (2002). A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med. 2: 7-12. (Pubitemid 34743942)
11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10: 111-113.
12. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG et al (1994). Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet. 7: 195-200. (Pubitemid 24174661)
13. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, D'Andrea G, Pavone G et al (1998). Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss. Thromb Haemost. 79: 1056-1057. (Pubitemid 28224749)
14. Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E et al (2000). Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet. 8: 725-729.
15. Huemer M, Vonbion K, Födinger M, Krumpholz R, Hubmann M, Ulmer H et al (2006). Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents. Pediatr Res. 60: 764-769. (Pubitemid 44789523)
16. Infante-Rivard C, Rivard GE, Guiquet M, Gauthier R (2005). Thrombophilic polymorphisms and intrauterine growth restriction. Epidemiology. 16: 281-287. (Pubitemid 40586701)
17. Jaaskelainen E, Keski-Nisula L, Toivonen S, Romppanen EL, Helisalmi S, Punnonen K et al (2006). MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy. 25: 73-80. (Pubitemid 44180348)
18. Jivraj S, Rai R, Underwood J, Regan L (2006). Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod. 21: 1161-1165.
19. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G (1988). Intermediate Homocysteinemia: A Thermolabile Variant of Methylenetetrahydrofolate Reductase. Am J Hum Genet. 43: 414-421.
20. Khong TY, Hague WM (1999). The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol. 106: 273-278.
21. Kim YI (2005). 5, 10-Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetcs: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. Nutr Rev. 63: 398-407.
22. Kordas K, Ettinger AS, Lamadrid-Figueroa H, Tellez-Rojo MM, Hernandez-Avilla M, Hu H et al (2009). Methylenetetrahydrofolate reductase (MTHFR) C677T, A1298C and G1793A genotypes, and the relationship between maternal folate intake, tibia lead and infant size birth. Br J Nutrition. 2: 1-8.
23. Kupfermine MJ (2005). Management of thrombophilia in women with PVC. Thromb Res. 115: 46-50.
24. Kutteh WH, Park VM, Deitcher SR (1999). Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 71: 1048-1053. (Pubitemid 29252494)
25. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici H (1999). Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol. 181: 126-130.
26. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV et al (2000). Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 343: 1015-1018.
27. Melo SS, Persuhn DC, Meirelles MS, Jordao AA, Vannucchi H (2006). G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels. Mol Nutr Food Res. 50: 769-774. (Pubitemid 44342474)
28. Mtiraoui N, Zammiti W, Ghazouani L, Braham NJ, Saidi S, Finan RR et al (2006). Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction. 131: 395-401. (Pubitemid 43273699)
29. Nelen WL, Bloom HJ, Steegers EA, den Heijer M, Eskes TK (2000). Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 74: 1196-1199.
30. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H et al (2002). Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet. 107: 162-168.
31. Rai R (2003). Is miscarriage a coagulopathy? Curr Opin Obstet Gynecol. 15: 265-268.
32. Rai R, Regan L (2006). Recurrent miscarriage. Lancet. 368: 601-611. (Pubitemid 44209184)
33. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R (2001). Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol. 45: 65-71. (Pubitemid 32111900)
34. Ren A, Wang H (2006). Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Fertil Steril. 86: 1716-1722.
35. Rey E, Kahn SR, David M, Shrier I (2003).Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 361: 901-908. (Pubitemid 36335814)
36. Rodriguez-Guillen Mdel R, Torres-Sanchez L, Chen J, Galvan-Portillo M, Blanco-Munoz J, Anaya MA et al (2009). Maternal MTHFR polymorphisms and risk of spontaneous abortion. Salud Publica Mex. 51: 19-25.
37. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998). A second genetic polymorphism in methylenetetrahydrofolate reductese (MTHFR) associated with decreased enzyme activity. Mol Genet Metabol. 64: 169-172. (Pubitemid 28453294)
38. Wiwanitkit V (2005). Roles of methylenetetrahydrofolate reductase C677T polymorphism in repeated pregnancy loss. Clin Appl Thromb Hemost. 11: 343-345.
39. Van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK et al (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 62: 1044-1051.
40. Yamada K, Chen Z, Rozen R, Matthews RG (2001). Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Nat Acad Sci. 98: 14853-14858. (Pubitemid 34013934)
41. Yilmaz H, Unlucerci Y, Gurdol F, Isbilen E, Isbir T (2004). Association of pre-eclampsia with hyperhomocysteinemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population. Aust NZJ Obstet Gynaecol. 44: 423-427. (Pubitemid 39485268)
42. Zetterberg H, Regland B, Palmér M, Ricksten A, Palmqvist L, Rymo L et al (2002). Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet. 10: 113-118. (Pubitemid 34414045)